痛みの少ないマイクロニードルパッチで腎疾患を早期検出できる可能性(A painless punch with a microneedle patch could detect kidney disease earlier)

ad

2026-08-24 ワシントン大学セントルイス校

ワシントン大学セントルイス校の研究チームは、痛みをほとんど伴わずに皮膚から間質液を採取し、腎疾患の早期発見に利用できるマイクロニードルパッチ型センサーを開発した。極めて細い針を皮膚に挿入して間質液を採取し、血液中のクレアチニン濃度と関連する代謝物を測定することで、腎機能を継続的にモニタリングできる可能性がある。研究では、マイクロニードルによって採取した間質液からクレアチニンを検出し、腎機能低下の指標として利用できることを示した。血液検査では採血が必要で、検査頻度にも限界があるのに対し、この技術は低侵襲で反復測定できる点が特徴である。研究チームは、将来的に家庭や診療現場で腎機能を簡便に監視し、急性腎障害や慢性腎臓病をより早期に発見するためのウェアラブル医療デバイスへの発展を目指している。

痛みの少ないマイクロニードルパッチで腎疾患を早期検出できる可能性(A painless punch with a microneedle patch could detect kidney disease earlier)
New research from the lab of Srikanth Singamaneni shows the early success of a microneedle patch that can be applied on the skin to quickly and safely capture biomarkers. The patch detected early signs of kidney injury and may one day support home or point-of-care monitoring. (Image: Singamaneni lab)

<関連情報>

金属有機構造体で保護された耐熱性マイクロニードルパッチを用いた腎機能障害の低侵襲的検出およびモニタリング Metal–Organic Framework-Preserved Thermostable Microneedle Patch for Minimally Invasive Detection and Monitoring of Kidney Dysfunction

Yixuan Wang, Ying Liu, Avishek Debnath, Chuang Li, Zheyu Wang, Gayathri Kondepati, Saketh Balmoori, Jeremiah J. Morrissey, Ying Maggie Chen, Limei Tian, Srikanth Singamaneni
Advanced Materials  Published: 05 August 2026
DOI:https://doi.org/10.1002/adma.74423

ABSTRACT

Early and decentralized biomarker detection and monitoring is essential for timely diagnosis and intervention, particularly in kidney disorders that often progress asymptomatically until irreversible damage has occurred. Here, we present a thermally resilient metal-organic framework encapsulated microneedle (MOF@MN) sensing platform that integrates minimally invasive dermal interstitial fluid (ISF) sampling and on-needle detection with MOF-based biostabilization of the sensing interface. A thin zeolitic imidazolate framework-8 (ZIF-8) shell is grown in situ on antibody-functionalized microneedles, preserving the bioactivity of immobilized antibodies after 4 weeks of thermal cycling up to 50°C and maintaining full analytical performance after prolonged unrefrigerated shipment. This interfacial encapsulation strategy enables quantitative detection of neutrophil gelatinase-associated lipocalin (NGAL), an early biomarker of kidney injury, directly from dermal ISF over a broad clinically relevant range. In a mouse model and human subjects, MOF@MN-derived NGAL measurements closely mirror blood NGAL concentrations, precede changes in conventional renal function markers, and correlate well with histopathological injury severity, highlighting their potential for subclinical monitoring. Collectively, this study establishes conformal MOF encapsulation as a simple and highly effective strategy for engineering environmentally resilient sensing interfaces and provides a scalable route to cold-chain-independent, minimally invasive biosensing for decentralized and at-home health monitoring.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました